Studies on breast, pancreatic, and lung cancer demonstrated that MFN2 inhibits cell proliferation or cancer progression through interact with RAS or suppression of phosphoinositide 3 kinase (PI3K)-protein kinase B (AKT) signaling11–14. The gene discussed is AKT1; the disease is lung carcinoma.